ORIGINAL ARTICLE
Patient characteristics and 6‐month dose of basal insulin associated with HbA1c achievement <7.0% in Chinese people with type 2 diabetes: results from the Observational Registry of Basal Insulin Treatment (ORBIT)
接受6个月基础胰岛素治疗糖化血红蛋白(HbA1c)达标(<7.0%)的中国2型糖尿病患者特征:来自基础胰岛素治疗登记观察性登记研究(ORBIT)的结果